Fingerprint
Dive into the research topics of 'A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer
Dan Laheru, Gary Croghan, Ronald Bukowski, Michelle Rudek, Wells Messersmith, Charles Erlichman, Robert Pelley, Antonio Jimeno, Ross Donehower, Joseph Boni, Richat Abbas, Patricia Martins, Charles Zacharchuk, Manuel Hidalgo
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations